The Australian pharmaceutical group CSL Behring has cut just under 10% of the workforce in Bern, the company announced on Thursday. In February, it emerged that the company was planning job cuts. Tamedia’s Bern-based publications cited a figure of around 180 jobs likely to be at risk – roughly 10% of the workforce. CSL Behring has now stated in a press release issued on Thursday that the transformation process has been completed and that the company has “strengthened its long-term competitive...